Vifor Pharma AG
A global leader in specialty pharmaceuticals for iron deficiency and nephrology.
VIFN | SW
Overview
Corporate Details
- ISIN(s):
- CH0364749348
- LEI:
- 529900KO6CN2D9OE1F19
- Country:
- Switzerland
- Address:
- Rechenstrasse 37, 9014 St. Gallen
- Website:
- https://www.viforpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CSL Vifor is a global specialty pharmaceuticals company and a leader in iron deficiency and nephrology therapies. As a pioneer in iron-based treatments, the company develops, manufactures, and markets innovative products for iron deficiency anemia and related conditions in areas including heart failure, gastroenterology, and women's health. In partnership with its joint company, Vifor Fresenius Medical Care Renal Pharma, CSL Vifor is expanding its presence in nephrology, committed to launching therapies that address the full spectrum of kidney disease. The company specializes in strategic global partnering, in-licensing, and marketing pharmaceutical products to serve patients with unmet medical needs in over 100 countries.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Vifor Pharma AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vifor Pharma AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vifor Pharma AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-09 | N/A | Executive member | Sell | None | 4,335,210.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,951,125.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,851,300.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 1,535,160.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 1,450,515.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 920,205.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 530,310.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 382,140.00 CHF |
| 2022-03-09 | N/A | Non-Executive member | Sell | None | 330,495.00 CHF |
| 2022-03-09 | N/A | Executive member | Sell | None | 287,925.00 CHF |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
